Results
1078
Companies which are more than 50% undervalued based on analyst price target.
1078 companies
Strategy
Market Cap: US$94.7b
Operates as a bitcoin treasury company in the United States, Europe, the Middle East, Africa, and internationally.
MSTR
US$327.79
7D
-0.6%
1Y
143.7%
Trade Desk
Market Cap: US$22.1b
Operates as a technology company in the United States and internationally.
TTD
US$45.15
7D
-13.2%
1Y
-57.2%
Rubrik
Market Cap: US$14.7b
Provides data security solutions to individuals and businesses worldwide.
RBRK
US$75.60
7D
-20.9%
1Y
140.9%
Duolingo
Market Cap: US$14.1b
Operates as a mobile learning platform in the United States, the United Kingdom, and internationally.
DUOL
US$285.11
7D
5.1%
1Y
21.8%
Summit Therapeutics
Market Cap: US$14.1b
A biopharmaceutical company, focuses on discovery, development, and commercialization of patient, physician, caregiver, and societal friendly medicinal therapies.
SMMT
US$18.94
7D
-2.6%
1Y
-35.8%
On Holding
Market Cap: US$14.0b
Engages in the development and distribution of sports products worldwide.
ONON
US$42.67
7D
-5.6%
1Y
-14.5%
QXO
Market Cap: US$14.0b
Distributes roofing, waterproofing, and other building products in the United States.
QXO
US$21.23
7D
-3.3%
1Y
54.4%
Aurora Innovation
Market Cap: US$10.5b
Operates as a self-driving technology company in the United States.
AUR
US$5.89
7D
2.2%
1Y
20.6%
U-Haul Holding
Market Cap: US$10.4b
Operates as a do-it-yourself moving and storage operator for household and commercial goods in the United States and Canada.
UHAL
US$56.33
7D
-2.7%
1Y
-22.9%
BioMarin Pharmaceutical
Market Cap: US$10.4b
A biotechnology company, engages in the development and commercialization of therapies for life-threatening rare diseases and medical conditions in the United States, Europe, Latin America, the Middle East, the Asia Pacific, and internationally.
BMRN
US$53.14
7D
-5.7%
1Y
-23.9%
Moderna
Market Cap: US$9.1b
A biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally.
MRNA
US$23.88
7D
-3.8%
1Y
-65.5%
Primo Brands
Market Cap: US$9.0b
Operates as a branded beverage company in North America.
PRMB
US$22.43
7D
-8.6%
1Y
-7.6%
Chime Financial
Market Cap: US$8.8b
A financial technology company, provides digital consumer banking and payment solutions.
CHYM
US$23.24
7D
-4.9%
1Y
n/a
Revolution Medicines
Market Cap: US$8.7b
A clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers.
RVMD
US$46.20
7D
12.5%
1Y
3.7%
Liberty Broadband
Market Cap: US$8.7b
Engages in a range of communications businesses in the United States.
LBRD.K
US$59.96
7D
-1.0%
1Y
-3.0%
Birkenstock Holding
Market Cap: US$8.5b
Engages in the manufacture and sale of footwear products.
BIRK
US$46.09
7D
-5.7%
1Y
-4.5%
Corcept Therapeutics
Market Cap: US$7.7b
Engages in discovery and development of medication for the treatment of severe endocrinologic, oncologic, metabolic, and neurologic disorders in the United States.
CORT
US$69.53
7D
-2.4%
1Y
80.7%
VinFast Auto
Market Cap: US$7.7b
Engages in the design and manufacture of electric vehicles (EV), e-scooters, and e-buses in Vietnam, Canada, and the United States.
VFS
US$3.24
7D
0.6%
1Y
-18.0%
Avidity Biosciences
Market Cap: US$6.4b
A biopharmaceutical company, engages in the delivery of RNA therapeutics called antibody oligonucleotide conjugates (AOCs).
RNA
US$40.19
7D
-16.4%
1Y
-3.7%
Repligen
Market Cap: US$6.4b
A life sciences company, develops and commercializes bioprocessing technologies and systems in North America, Europe, the Asia Pacific, and internationally.
RGEN
US$113.74
7D
-5.8%
1Y
-18.8%
Cytokinetics
Market Cap: US$6.1b
A late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases in the United States.
CYTK
US$49.44
7D
-5.1%
1Y
-12.9%
Legend Biotech
Market Cap: US$6.1b
Through its subsidiaries, operates as a biopharmaceutical company that discovers, develops, manufactures, and commercializes novel cell therapies for oncology and other indications in the United States, China, and Europe.
LEGN
US$33.88
7D
-2.1%
1Y
-33.9%
Axsome Therapeutics
Market Cap: US$5.9b
A biopharmaceutical company, develops and delivers novel therapies for the management of central nervous system (CNS) disorders in the United States.
AXSM
US$116.78
7D
-9.7%
1Y
26.4%
Clearwater Analytics Holdings
Market Cap: US$5.9b
Develops and provides a Software-as-a-Service (SaaS) solution for automated investment data aggregation, reconciliation, accounting, and reporting services to insurers, investment managers, corporations, institutional investors, and government entities in the United States and internationally.
CWAN
US$19.36
7D
-5.1%
1Y
-21.0%
Bath & Body Works
Market Cap: US$5.6b
Operates as a specialty retailer of home fragrance, personal and body care, soaps, and sanitizer products.
BBWI
US$26.46
7D
-7.1%
1Y
-8.5%
Caesars Entertainment
Market Cap: US$5.2b
Operates as a gaming and hospitality company.
CZR
US$25.90
7D
-1.8%
1Y
-34.3%
Glaukos
Market Cap: US$4.7b
An ophthalmic pharmaceutical and medical technology company, develops therapies for the treatment of glaucoma, corneal disorders, and retinal diseases in the United States and internationally.
GKOS
US$80.64
7D
-12.2%
1Y
-35.1%
OneStream
Market Cap: US$4.6b
OneStream, Inc. delivers a unified, AI-enabled, and extensible software platform in the United States and internationally.
OS
US$18.53
7D
-8.2%
1Y
-39.1%
Alkermes
Market Cap: US$4.5b
A biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in therapeutic areas in the United States, Ireland, and internationally.
ALKS
US$26.52
7D
-6.8%
1Y
-4.7%
Arcellx
Market Cap: US$4.2b
Together with its subsidiary, engages in the development of various immunotherapies for patients with cancer and other incurable diseases in the United States.
ACLX
US$75.20
7D
5.8%
1Y
-2.4%
Vaxcyte
Market Cap: US$4.2b
A clinical-stage vaccine innovation company, develops conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases.
PCVX
US$31.00
7D
-4.4%
1Y
-72.9%
Arrowhead Pharmaceuticals
Market Cap: US$4.1b
Develops medicines for the treatment of intractable diseases in the United States.
ARWR
US$28.67
7D
5.5%
1Y
40.2%
ADMA Biologics
Market Cap: US$3.8b
A biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally.
ADMA
US$15.30
7D
-6.8%
1Y
-15.9%
Vertex
Market Cap: US$3.8b
Provides enterprise tax technology solutions for retail trade, wholesale trade, and manufacturing industries in the United States and internationally.
VERX
US$24.05
7D
-7.3%
1Y
-33.9%
Globalstar
Market Cap: US$3.8b
Provides mobile satellite services in the United States, Canada, Europe, Central and South America, and internationally.
GSAT
US$31.17
7D
-17.8%
1Y
73.2%
Accelerant Holdings
Market Cap: US$3.8b
Accelerant Holdings, together with its subsidiaries, operate a data-driven risk exchange that connects selected specialty insurance underwriters with risk capital partners.
ARX
US$17.57
7D
-13.1%
1Y
n/a